US FDA looks to increase domestic, foreign drug manufacturer inspections
The number of foreign inspections by the US FDA is expected to grow at a faster rate in FY 2015 than the increase in domestic inspections.
Archives for March 17, 2014
ClinicalRM, PPD awarded BARDA countermeasure contracts
CROs Clinical Research Management (ClinicalRM) and PPD were awarded contracts by the Biomedical Advanced Research and Development Authority (BARDA) to develop medical countermeasures.
Opportunities outweigh risks in China, says Eli Lilly
Eli Lilly says the opportunities in China outweigh any perceived challenges as it begins a $70m expansion of its manufacturing joint venture.
CFS Clinical selects C3i to provide tech support
CFS Clinical has selected C3i to provide global 24x365 multilingual technology support services for their site activation and investigator payment services.
Indian Courts asked to revoke Ranbaxy's manufacturing license
The Indian Supreme Court has been asked to cancel Ranbaxy’s manufacturing license in the wake of quality problems that earned the firm a US import ban.
Aesica predicts more CMO consolidation and hints at acquisitions
Aesica has predicted that CMO sector consolidation will continue and hinted that it is considering strategic acquisitions as a part of a bid to generate $1bn revenue.
‘Arrogance’ and animal testing: the hurdles to outsourcing
Pharmaceutical companies need to change their attitudes to contractors, says the former director of Shire’s relationships with its 100 outsourcing partners.